FDA Issues Final Regulations on Dissemination of Information on Unapproved Uses for Marketed Drugs, Biologics, and Devices

Summary

The US Food and Drug Administration (FDA) has released final rules governing the sharing of information about unapproved uses for approved medications, biologics, and medical devices, outlining procedures for manufacturers to submit data and seek exemptions or extensions.